Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · IEX Real-Time Price · USD
3.985
+0.185 (4.87%)
At close: Jul 26, 2024, 3:58 PM
3.550
-0.435 (-10.92%)
After-hours: Jul 26, 2024, 7:48 PM EDT
Phio Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
2.03M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPHIO News
- 15 days ago - Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds - Newsfile Corp
- 19 days ago - Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762 - Newsfile Corp
- 22 days ago - Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds - Newsfile Corp
- 24 days ago - Phio Pharmaceuticals Announces Reverse Stock Split - Newsfile Corp
- 5 weeks ago - Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging - Newsfile Corp
- 2 months ago - Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762 - Newsfile Corp
- 2 months ago - Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO) - Newsfile Corp
- 2 months ago - Phio Pharmaceuticals Secures New Investor - GlobeNewsWire